8OHW

Crystal structure of heparanase from Burkholderia pseudomallei in complex with siastatin B derived inhibitor


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.27 Å
  • R-Value Free: 0.181 
  • R-Value Work: 0.160 

Starting Model: experimental
View more details

wwPDB Validation   3D Report Full Report


Ligand Structure Quality Assessment 


This is version 1.2 of the entry. See complete history


Literature

Molecular Basis for Inhibition of Heparanases and beta-Glucuronidases by Siastatin B.

Chen, Y.van den Nieuwendijk, A.M.C.H.Wu, L.Moran, E.Skoulikopoulou, F.van Riet, V.Overkleeft, H.S.Davies, G.J.Armstrong, Z.

(2024) J Am Chem Soc 146: 125-133

  • DOI: https://doi.org/10.1021/jacs.3c04162
  • Primary Citation of Related Structures:  
    8CQI, 8OGX, 8OHQ, 8OHR, 8OHT, 8OHU, 8OHV, 8OHW, 8OHX

  • PubMed Abstract: 

    Siastatin B is a potent and effective iminosugar inhibitor of three diverse glycosidase classes, namely, sialidases, β- d -glucuronidases, and N -acetyl-glucosaminidases. The mode of inhibition of glucuronidases, in contrast to sialidases, has long been enigmatic as siastatin B appears too bulky and incorrectly substituted to be accommodated within a β- d -glucuronidase active site pocket. Herein, we show through crystallographic analysis of protein-inhibitor complexes that siastatin B generates both a hemiaminal and a 3-geminal diol iminosugar (3-GDI) that are, rather than the parent compound, directly responsible for enzyme inhibition. The hemiaminal product is the first observation of a natural product that belongs to the noeuromycin class of inhibitors. Additionally, the 3-GDI represents a new and potent class of the iminosugar glycosidase inhibitor. To substantiate our findings, we synthesized both the gluco - and galacto -configured 3-GDIs and characterized their binding both structurally and kinetically to exo-β- d -glucuronidases and the anticancer target human heparanase. This revealed submicromolar inhibition of exo-β- d -glucuronidases and an unprecedented binding mode by this new class of inhibitor. Our results reveal the mechanism by which siastatin B acts as a broad-spectrum glycosidase inhibitor, identify a new class of glycosidase inhibitor, and suggest new functionalities that can be incorporated into future generations of glycosidase inhibitors.


  • Organizational Affiliation

    Leiden Institute of Chemistry, Leiden University, Einsteinweg 55, 2300 RA Leiden, The Netherlands.


Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Glycoside hydrolase family 44 domain-containing proteinA [auth AAA],
B [auth BBB]
438Burkholderia pseudomalleiMutation(s): 0 
Gene Names: BPSL2070
UniProt
Find proteins for Q63T97 (Burkholderia pseudomallei (strain K96243))
Explore Q63T97 
Go to UniProtKB:  Q63T97
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ63T97
Sequence Annotations
Expand
  • Reference Sequence
Small Molecules
Ligands 2 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
VON (Subject of Investigation/LOI)
Query on VON

Download Ideal Coordinates CCD File 
C [auth AAA],
H [auth BBB]
(3~{S},4~{S},5~{S},6~{R})-4,5,6-tris(oxidanyl)piperidine-3-carboxylic acid
C6 H11 N O5
ZIPHSWANMLXHEB-NEEWWZBLSA-N
EDO
Query on EDO

Download Ideal Coordinates CCD File 
D [auth AAA]
E [auth AAA]
F [auth AAA]
G [auth AAA]
I [auth BBB]
D [auth AAA],
E [auth AAA],
F [auth AAA],
G [auth AAA],
I [auth BBB],
J [auth BBB],
K [auth BBB],
L [auth BBB]
1,2-ETHANEDIOL
C2 H6 O2
LYCAIKOWRPUZTN-UHFFFAOYSA-N
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.27 Å
  • R-Value Free: 0.181 
  • R-Value Work: 0.160 
  • Space Group: P 21 21 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 76.37α = 90
b = 104.61β = 90
c = 113.71γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
DIALSdata reduction
DIALSdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Netherlands Organisation for Scientific Research (NWO)NetherlandsVI.Veni.212.173
European Research Council (ERC)European UnionERC-2011-AdG-290836
European Research Council (ERC)European UnionERC-2012-AdG-32294
European Research Council (ERC)European UnionERC-2020-SyG-951231
Biotechnology and Biological Sciences Research Council (BBSRC)United KingdomBB/R001162/1
Biotechnology and Biological Sciences Research Council (BBSRC)United KingdomBB/M011151/1

Revision History  (Full details and data files)

  • Version 1.0: 2024-01-10
    Type: Initial release
  • Version 1.1: 2024-01-24
    Changes: Database references
  • Version 1.2: 2024-11-13
    Changes: Structure summary